Ginkgo & Raynaud’s

Livestrong.com
3/29/2011

Overview

Ginkgo biloba is one of the world’s oldest tree species. People cultivate ginkgo trees not only for their beauty, but because they are thought to have medicinal properties. In traditional medicine, ginkgo seeds and leaves have been used to treat circulatory disorders and respiratory diseases. More recently, ginkgo biloba was tested as a potential treatment for symptoms of Raynaud’s syndrome, a painful condition affecting some people’s fingers and toes during cold weather.

Raynaud’s Association Caution: Historical results for the treatment of Raynaud’s with Ginkgo Biloba shows some promise – but to date, the improvements have been found insignificant in clinical trials. Supplements can interact with other medications and herbal remedies. Their use should be discussed first with your doctor. [Read more...]

Happy First Day of Spring!!!

How did you celebrate???

Snoopy Dance - Mid-Compressed

Cialis Shown to Help Patients with Rare Blood Disorder

A drug used to treat erectile dysfunction, is showing promise for patients suffering from a rare blood condition.  Raynaud’s disease is a condition that causes discoloration of fingers and toes.  When people with Raynaud’s disease are exposed to the cold, their blood vessels close causing their fingers or toes to turn white or red.  Some doctors believe stress can also bring on these sudden symptoms and in severe cases the condition can lead to finger ulcers and scarring. [Read more...]

Autoimmune Disease Patient Education Panel

The Hackensack NJ Support Group of the Tri-State Scleroderma Foundation is sponsoring an

Autoimmune Disease
Patient Education Panel

[Read more...]

FDA Approves Drug to Treat Lupus

WSJ Lupus Drug Headline

Good news for fellow Frosties with Lupus!

HEALTH INDUSTRY
MARCH 9, 2011, 6:22 P.M. ET

Wall Street Journal

The Food and Drug Administration approved a new lupus drug from Human Genome Sciences Inc. and GlaxoSmithKline PLC, marking the first new treatment for the autoimmune disease in more than 50 years. [Read more...]

Sildenafil (Viagra) Reduces Raynaud’s Frequency in Patients with Scleroderma

 

  Modified-Release Therapy is Well Tolerated in Clinical Trial

Researchers in Europe reported that treatment with modified-release sildenafil significantly reduced the frequency of attacks of Raynaud’s phenomenon in patients with limited cutaneous systemic sclerosis (lcSSc), also known as scleroderma. The double-blind, placebo-controlled trial found that sildenafil was well tolerated with only some subjects experiencing minor or moderate side effects. Full findings are available in the March issue of Arthritis & Rheumatism, a journal published by Wiley-Blackwell on behalf of the American College of Rheumatology (ACR). [Read more...]

Who controls the thermostat in your home?

 

Sound Familiar???

 

http://www.cnn.com/2011/HEALTH/03/02/thermostat.arguments/